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Abstract
Background: In myocardial infarction (MI) a short pre-hospital delay, prompt diagnosis and timely reperfusion treatment
can improve the prognosis. Despite the importance of timely care seeking, many patients with MI symptoms delay
seeking medical care. Previous research is inconclusive about differences in symptom presentation and pre-hospital delay
between patients with and without diabetes during MI. The aim of this study was to describe symptoms and patient
delay during MI in patients with and without diabetes.
Methods: Swedish cross-sectional multicentre survey study enrolling MI patients in 5 centres within 24 h from
admittance.
Results: Chest pain was common in patients both with and without diabetes and did not differ after adjustment for
age and sex. Patients with diabetes had higher risk for shoulder pain/discomfort, shortness of breath, and tiredness, but
lower risk for cold sweat. The three most common symptoms reported by patients with diabetes were chest pain, pain
in arms/hands and tiredness. In patients without diabetes the most common symptoms were chest pain, cold sweat
and pain in arms/hands. Median patient delay time was 2 h, 24 min for patients with diabetes and 1 h, 15 min for
patients without diabetes (p = 0.024).
Conclusion: Chest pain was common both in patients with and without diabetes. There were more similarities than
differences in MI symptoms between patients with and without diabetes but patients with diabetes had considerably
longer delay. This knowledge is important not only for health care personnel meeting patients with suspected MI, but
also for the education of people with diabetes.
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Background
A short pre-hospital delay, leading to prompt diagnosis
and treatment of patients with a myocardial infarction
(MI), can reduce mortality, improve prognosis, and
shorten the hospital stay [1–3]. Despite the importance
of timely care seeking, many patients delay their first
medical contact (FMC) [4], leading to increased morbidity
and mortality because treatment is not given in a timely
manner [3]. Pre-hospital delay can be divided into three
phases: 1) patient decision time, from symptom onset to
the decision to seek medical care; 2) the time from the
decision to FMC; and 3) the time from FMC to hospital
arrival, including the transportation time. Transportation
to the hospital contributes only a little to pre-hospital
delay; the patient’s decision time constitutes the greatest
part of total pre-hospital delay [5].
Findings based on in-depth interviews show that the
interpretation of symptoms and the decision to seek
medical care during an MI are multifaceted and complex
[6–9]. Symptoms are key factors in the representation of
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a health threat [10] and the experience and interpret-
ation of symptoms are important factors in deciding
how to act and respond to signs and symptoms. Misinter-
preting symptoms or not taking them seriously have been
described associated with longer patient delay [6, 9, 11]. A
previous literature review found that socio-demographic,
clinical, cognitive, psychological, behavioural, and context-
ual factors influence patient delay and are important in
understanding the phenomenon of delay [12]. Older age
[13, 14], female sex [4, 14], and comorbidities [13, 15] have
been found to be associated with prolonged delays accord-
ing to previous research.
Previous research is inconclusive on whether there
are differences between patients with and without dia-
betes regarding symptoms and pre-hospital delays
times. Some studies have demonstrated that patients
with diabetes less frequently report chest pain [16] and
have longer pre-hospital delays [17],while others have
found no such differences [15, 18, 19]. Because diabetes
is associated with an increased risk of developing MI
[20] and a lower post-MI survival rate [21–23], it is
crucial that patients with diabetes recognize possible
MI symptoms and seek care promptly. Better under-
standing of symptom presentation and patient delay
times in patients with diabetes is needed to improve
time to treatment. Therefore, the aim of our study was
to describe symptoms and patient delay during MI in
patients with and without diabetes.
Methods
This study is a part of a Swedish multicentre survey study,
SymTime, and had a descriptive and comparative cross-
sectional design. The study was performed between
November 2012 and January 2014 with participants
from five hospitals in northern and southeast Sweden.
Participants
The study population consisted of 694 patients hospi-
talized with MI. Patients were eligible if they (i) had a
diagnosis of ST-elevation MI (STEMI) or non-ST-
elevation MI (NSTEMI) according to the European
Society of Cardiology guidelines [3, 24], (ii) were willing
to participate, and (iii) were able to fill in the question-
naire by themselves or with help from hospital
personnel or family. Participants were enrolled in the
study within 24 h of their admission to the coronary
care unit and should be clinically stable at the time
point of inclusion.
Data collection
A previously validated self-administered questionnaire
was used to access self-reported data on symptoms, pre-
hospital delay, and initial response to symptoms in MI
patients. This questionnaire was originally developed
and tested a decade ago in a Swedish chest pain popula-
tion (i.e., acute MI, angina pectoris, and/or non-cardiac
chest pain) [19]. Prior to the present study, a new review
of the literature and expert validation of the question-
naire were conducted in collaboration with the original
developer. This validation procedure is described previ-
ously [25]. The modified questionnaire included 35 items
covering four domains; (i) background characteristics (sex,
age, marital status, medical history, distance to nearest
hospital, and educational level), (ii) symptoms (how pa-
tients experienced and attributed their symptoms, and
how they rated their pain or discomfort on a numeric rat-
ing scale (NRS) of 0–10, (iii) course of events (e.g., actions
taken after symptom onset; whether or not they were
alone; who they contacted first; whether they practiced
any self-care); and finally, (iv) mode of transport to hos-
pital, including time point measurements based on pa-
tients’ statements.
The modified questionnaire was administered to the
patients by the staff nurse in charge or the nurse re-
sponsible for the study at each hospital. The patients
were instructed to choose the alternative (s) that best
reflected their pre-hospital experiences. Data about
diabetes, hypertension, heart failure, previous MI, pre-
vious angina, and smoking habits were self-reported
(from options on the questionnaire). Patients with dia-
betes included both patients with diabetes type 1 and
type 2. In addition, information about comorbidities,
certain time point measurements, and FMC was regis-
tered by the nurse responsible for the patient. Patient
delay time was defined as the time interval between
onset of symptoms and FMC. FMC was defined as the
first contact the patient made with any of emergency
medical service (EMS), Primary Healthcare, Swedish
Healthcare Direct (a joint service number, 1177,
staffed by advisory nurses 24/7) or emergency room.
Statistical methods
Characteristics of the participants were described using
frequencies, proportions, means (m), and standard devi-
ations (sd) and medians (Md) and quartiles (Q1, Q3).
Comparisons between groups were made using chi-
square test, Fisher’s exact test, Mann-Whitney U test,
and Student t-test as appropriate. Multiple logistic re-
gression analyses were used to adjust for age and sex.
Delays in patients with and without diabetes were com-
pared non-parametrically with Mann-Whitney U test as
the distribution was non-normal. We dichotomised pa-
tient delay time using < 2 h/≥ 2 h as cut-of, and chi-
square test was used to test for difference between
groups in univariate analyses. To adjust for age and sex
multiple logistic regression was used. A p-value < 0.05
was considered significant. The statistical analyses were
performed using SPSS version 22.0 for Windows.
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Ethical aspects
Patients were hemodynamically stable and pain free
when they were informed about the study and asked to
participate. A written consent was obtained from the
patients before inclusion in the study. This study
was approved by the regional Ethical Review Board,
Linköping, Sweden (D-nr 2012/201-31, 2012/338-32),
and conformed with the Declaration of Helsinki [26].
Results
Of the 694 participants, 96 (13.8 %) had diabetes. The
mean age was 66.5 (sd 12.1) in patients with diabetes and
65.9 (sd 11.2) in patients without. Patients with diabetes
had a significantly higher prevalence of hypertension and
angina pectoris. The diabetes group included a higher
proportion of women (p = 0.051) and individuals with
previous MI (p = 0.055) than the non-diabetes group.
Other background characteristics were quite similar be-
tween the groups (Table 1).
Symptoms and symptom interpretations
Chest/thoracic pain, discomfort, or pressure was the most
common symptom reported among patients with and
without diabetes. In the univariate analyses, patients with
diabetes reported chest/thoracic pain, discomfort, or pres-
sure significantly less often than patients without diabetes
(81.3 % vs 89.5 %, p = 0.020). After adjusting for age and
sex, this difference did not reach significance (p = 0.065)
(Table 2). The three most common symptoms reported by
patients with diabetes were chest pain, pain in arms/hands
and tiredness. In patients without diabetes the most com-
mon symptoms were chest pain, cold sweat and pain in
arms/hands. Even after adjustment for age and sex, pa-
tients with diabetes had higher risk for shoulder pain/dis-
comfort, shortness of breath, and tiredness but lower risk
for cold sweats. There were no significant between-group
differences in other symptoms (Table 2).
Of the 18 possible symptoms presented in the ques-
tionnaire, there was no difference in number of reported
symptoms between patients with and without diabetes,
Table 1 Background characteristics of the participants
Background characteristics Patients with diabetes, n = 96 Patients without diabetes, n = 598 p-value
Age, mean (sd) 66.5 (12.1) 65.9 (11.2) 0.6
Sex, male, n (%) 65 (67.7) 460 (76.9) 0.051
Distance to hospital, n (%)a
≤1 km 8 (8.3) 35 (6.0) 0.6
1–10 km 32 (33.3) 208 (35.4)
10–50 km 38 (39.6) 254 (43.2)
> 50 km 18 (18.8) 91 (15.5)
Marital status, n (%)
Married/cohabitant 66 (68.8) 429 (71.7) 0.5
Educational level, n (%)a
Compulsory school 48 (50.0) 253 (42.4) 0.4
Gymnasium 31 (32.3) 221 (37.1)
Higher education 17 (17.7) 122 (20.5)
History of, n (%)a
Hypertension 80 (83.3) 249 (42.1) <0.001
Angina pectoris 25 (27.8) 78 (13.3) <0.001
Atrial fibrillation 7 (7.8) 32 (5.5) 0.4
Heart failure 5 (5.5) 17 (2.9) 0.2
MI 20 (22.0) 84 (14.2) 0.055
Stroke 5 (5.2) 21 (3.5) 0.4
Current smoker 18 (18.8) 132 (22.3) 0.4
Type of infarction, n (%)a
STEMI 74 (77.1) 458 (76.6) 0.9
NSTEMI 22 (22.9) 140 (23.4)
aDifferences in percentages are due to missing responses
Significant results (p < 0.05) are presented in bold style
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median 5.0 (p = 0.600). There was also no difference in
pain intensity between patients with and without dia-
betes, median 7 on NRS. More than half of the partici-
pants in both groups described the pain as “persistent”,
followed by “come and go” or “increasing”, and only a
few described the pain as “transient”. There were no sig-
nificant differences between the groups in the descrip-
tions of pain continuity (Table 3).
About two thirds of the participants in both groups
reported interpreting the symptoms as originating
from the heart (Table 3). The second and third most
common attributions of the origin of the symptoms
were the stomach (30.6 % in patients with diabetes vs.
35.5 % in patients without diabetes) and the muscles
(30.6 % in patients with diabetes vs 28.1 % in patients
without diabetes), with no significant differences
Table 2 Symptom presentation in patients with and without diabetes. Crude and adjusted odds ratio (OR) and confidence interval
(CI) for having different symptoms
Symptoms Patients with diabetes, n = 96 Patients without diabetes, n= 598
Pain, discomfort, or pressure location n (%) n (%) Crude OR (95 % CI) Adjusted OR (95 % CI)
Chest or thoracic 78 (81.3) 535 (89.5) 0.51 (0.29–0.91) 0.57 (0.31–1.04)
Throat or neck 25 (26.0) 118 (19.7) 1.43 (0.87–2.36) 1.36 (0.82–2.25)
Jaw or teeth 15 (15.6) 65 (10,9) 1.52 (0.83–2.79) 1.44 (0.78–2.67)
Back 18 (18.8) 99 (16.6) 1.16 (0.67–2.03) 1.07 (0.60–1.88)
Stomach 10 (10.4) 48 (8.0) 1.33 (0.65–2.73) 1.36 (0.66–2.80)
Shoulders 34 (35.4) 110 (18.4) 2.43 (1.53–3.88) 2.30 (1.43–3.70)
Arms/hands 50 (52.1) 331 (55.4) 0.88 (0.57–1.35) 0.84 (0.54–1.30)
Other symptoms
Numbness in arms/hands 24 (25.0) 183 (30.6) 0.76 (0.46–1.24) 0.76 (0.46–1.25)
Tiredness 41 (42.7) 186 (31.1) 1.65 (1.06–2.56) 1.62 (1.03–2.52)
Weakness 37 (38.5) 234 (39.1) 0.98 (0.63–1.52) 0.96 (0.61–1.49)
Shortness of breath 40 (41.7) 184 (30.8) 1.61 (1.03–2.50) 1.61 (1.03–2.51)
Vertigo/pre-syncope 23 (24.0) 140 (23.4) 1.03 (0.62–1.71) 1.02 (0.61–1.69)
Nausea/vomiting 26 (27.1) 181 (30.3) 0.86 (0.53–1.39) 0.78 (0.47–1.28)
Cold sweat 40 (41.7) 333 (55.7) 0.57 (0.37–0.88) 0.56 (0.36–0.86)
Anxiety 12 (12.5) 79 (13.2) 0.94 (0.49–1.80) 0.92 (0.48–1.77)
Fear 18 (18.8) 132 (22.1) 0.82 (0.47–1.41) 0.77 (0.44–1.34)
General sick feeling 16 (16.7) 88 (14.7) 1.16 (0.65–2.08) 1.09 (0.61–1.97)
Other 9 (9.4) 41 (6.9) 1.40 (0.66–2.99) 1.37 (0.64–2.94)
Significant results are presented in bold style. Adjusted OR: adjusted for age and sex
Table 3 Symptom characteristics and symptom interpretation in patients with and without diabetes
Patients with diabetes, n = 96 Patients without diabetes, n = 598 p-value
How the pain occurred, n (%)
-Transient 5 (5.4) 17 (2.9) 0.7
-Come and go 23 (24.7) 145 (24.9)
-Persistent 48 (51.6) 317 (54.4)
-Increasing 17 (18.3) 104 (17.8)
Interpretation of symptoms as originating from the heart, n (%) 64 (66.7) 398 (66.7) 1.0
Number of symptoms >5, n (%) 43 (44.8) 223 (37.3) 0.2
Number of symptoms, Md [Q1,Q3] 5.0 [3.0,7.0] 5.0 [3.0,6.0] 0.6
Pain intensity, NRS, Md [Q1,Q3] 7.0 [6.0,8.0] 7.0 [6.0,8.0] 0.9
NRS numeric rating scale of 0–10
Ängerud et al. BMC Cardiovascular Disorders  (2016) 16:108 Page 4 of 8
between the groups. Of those who did not interpret
the symptoms as originating from the heart, more
patients with diabetes than without were “entirely sure
the symptoms did not originate from the heart”
(62.9 % vs. 40.5 %, p = 0.013).
Patient delay time
Median patient delay time from symptom onset to FMC
was 2 h, 24 min (Q1, 0:44; Q3 6:55) for patients with dia-
betes and 1 h, 15 min, (Q1 0:31; Q3 3:17) for patients
without diabetes. The difference in median delay, 1 h,
09 min, was statistically significant (p = 0.024). Approxi-
mately 54 % of patients with diabetes delayed for 2 h or
more compared with 36 % of patients without diabetes
(p = 0.002), and 26 % of patients with diabetes and 16 %
of patients without diabetes had delay times that
exceeded 6 h (p =0.021) (Fig. 1). After adjustments for
sex and age, patients with diabetes had higher risk for
delay of ≥ 2 h, OR 2.04 (95 % CI: 1.26-3.30, p = 0.004).
Discussion
In this multicentre study, we found that patients with
diabetes had a considerable longer patient delay com-
pared to patients without diabetes, with a difference of
1 h and 9 min between the groups. As many as half of
patients with diabetes exceeded 2 h delay, making the
goal of a total ischemic time under 2 h impossible [1].
Also after adjusting for age and sex, diabetes was signifi-
cantly associated to a patient delay exceeding 2 h. The
prolonged delay is consistent with a previous study
based on The Northern Sweden MONICA myocardial
infarction registry, which also found that diabetes was
associated with pre-hospital delay for more than 2 h
[27]. Furthermore, it has also been shown that patients
with diabetes have delayed initiation of reperfusion treat-
ments, leading to longer ischemic time [28, 29] contrib-
uting to their worse outcome in MI.
The reason for longer delays in diabetes is obscure
and still debated. Diabetes is a well-known risk factor for
development of ischemic heart disease and patients with
diabetes ought to be informed by their health care pro-
viders about MI symptoms and warning signs, and thus
be able to seek care more promptly than patients with-
out diabetes. Instead the opposite is found in our as well
as previous studies [13, 17]. In the present study some
differences in symptom presentation were found, such as
more shoulder pain/discomfort, shortness of breath, and
tiredness in patients with diabetes - symptoms that may
not be associated with MI and thus have caused a pro-
longed delay. This is in line with previous research that
found that dyspnea [16, 18] and fatigue [30] were more
common in patients with diabetes. Kentch et al. [18]
suggest that the higher prevalence of dyspnea in patients
with diabetes might be due to a more severe stage of
coronary artery disease among these patients. This could
also be a possible explanation in our study since patients
with diabetes more often had previous angina pectoris
and a history of MI. In the current study patients with
diabetes were less likely to experience cold sweat, which
might be due to diabetic autonomic neuropathy, in
which loss of sweating can be one of the symptoms [31].
Tiredness can be difficult to evaluate, especially without
Fig. 1 Distribution of time from symptom onset to first medical contact in patients with and without diabetes
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concurrent chest pain, since such diffuse symptom can
be present in many different diseases including diabetes
[32, 33].
On the other hand chest pain/discomfort during MI
was just as common in patients with diabetes and those
without and there were no differences in pain intensity
or number of symptoms. Similar findings of no differ-
ences in chest pain [18, 34] or pain intensity [18] are
previously reported while other studies have found that
patients with diabetes less frequently experience chest
pain in MI [16, 35]. The latter are older than the present
study, with data collected between 1990–1995 [16] and
1994–1998 [35] and this can contribute to the divergent
results. Modern diabetic treatment and better glucose
control may have decreased diabetes complications, such
as cardiac autonomic neuropathy - a complication that
can lead to absence of chest pain [36].
There are also other factors, such as symptom inter-
pretation that may contribute to patient delay. Previous
research has shown that the evaluation of symptoms in
the presence of chronic illness might be difficult [37, 38].
A qualitative meta-analysis of heart failure self-care
among people with multiple comorbid conditions reports
that the patient’s perceptions of self-care might interact
with fragmented information from different providers.
This makes it difficult when patients are forced to make
decisions about their symptoms; for example, whether the
symptoms are related to their diabetes, their kidneys, or
their heart [38]. Patients with diabetes in the present study
often had concomitant hypertension and angina pectoris,
and that might have affected their symptom interpretation
and their decision to seek medical care.
In our study, only 67 % of patients interpreted their
symptoms as cardiac in origin. This is somewhat surpris-
ing because over 80 % in both groups reported chest
pain, and people often recognize chest pain as a symp-
tom of MI [39]. It is possible that other factors such as
intermittent symptoms confuse patients who might ex-
pect MI to have a sudden onset and persistent symp-
toms. In this study, about one quarter in both groups
reported the symptoms to “come and go”. A previous
study found that 65 % of patients with acute coronary
syndrome experienced a slow onset presentation (de-
scribed as any typical or atypical MI symptom with grad-
ual onset, mild intensity, and intermittent nature) [40].
Strengths and limitations
This study offers new insights about symptoms and the
pre-hospital phase in patients with diabetes. The
strength of this study is underscored by the inclusion of
a large number of patients from five hospitals and from
different areas of Sweden, adding to the external validity
of our findings. Patients were included within 24 h after
admission to hospital and the time limit was chosen to
reduce the risk of recall bias. We applied no age re-
straints, therefore the generalizability should be high, at
least for Swedish health care. Using a validated question-
naire covering the most important aspects of patient
delay was supplemented by a thorough analysis of object-
ively noted time points in the medical journals, including
those from ambulance transports. One limitation is that
participants had to be pain free and hemodynamically
stable before participating in the study. Some patients ad-
mitted during the study period were not stabilized within
24 h, and this might mean that the sickest patients were
not included in the study. Another limitation is that the
self-reported questionnaire is only available in Swedish,
which might complicate comparisons with other studies.
There is also a possibility that patients’ memories of their
pre-hospital experiences were affected by analgesic and
sedative drugs.
Implications
The knowledge gained from our study is important not
only for health care personnel meeting patients with a
suspected MI, but also for the education of people with
diabetes. Most patients with diabetes have regular con-
tact with diabetes specialist nurses or doctors that allows
them to have face-to-face discussions about symptoms
and how to react if MI symptoms occur. Patient educa-
tion needs to emphasize the possibility that MI could
start with diffuse symptoms such as tiredness and short-
ness of breath and that MI could present as a slow onset
event with intermittent symptoms. Knowledge about dif-
ferences in symptoms may also be used to design inter-
ventions aiming to reduce prehospital delay in patients
with diabetes. A reduction in patient delay time among
patients with diabetes can improve survival since longer
prehospital delay in patients with diabetes might con-
tribute to their worse outcome in MI compared to pa-
tients without diabetes.
Conclusions
Our study demonstrated that patients with diabetes
had longer patient delay than patients without dia-
betes. Chest pain was just as common both in pa-
tients with and without diabetes, and there were no
differences in the number of MI symptoms or symp-
tom intensity. This study also showed that many pa-
tients with diabetes have other chronic illnesses such
as hypertension and angina that might complicate
their interpretation of symptoms. Further research is
needed into how people with a chronic illness such
as diabetes respond to new acute symptoms such as
those of MI and how the health care system can
support them in decision making despite their differ-
ent diseases.
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